Sichenzia Ross Ference LLP以800万美元的私人配售代表AIT Therapeutics

AIT therapeutics

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (NASDAQ:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, in a $8 million private placement of its common stock.

The Company issued approximately 1.6 million shares of common stock at a purchase price of $5.00 per share.  The private placement was made directly by the Company without an underwriter or placement agent.

The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia and Avital Perlman.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP是一家提供全方位服务的律师事务所,拥有国家认可的公司,证券和诉讼业务,可在涉及证券行业的所有事务中提供有经验的代表。除了处理日常的复杂商业事务外,SRF著名的诉讼部门还专门针对各种类型的证券案件为公司和个人提供辩护,包括集体诉讼,股东衍生诉讼以及涉及欺诈,虚假陈述或其他违反证券的指控。诉讼团队还对与市场操纵有关的公司和个人提起了诽谤诉讼。此外,它还代表个人和公司接受证券交易委员会(SEC)和其他监管机构的调查。诉讼团队在向金融业监管局(FINRA)进行仲裁时,代表经纪人和经纪人-交易商采取有力的做法。这些仲裁通常涉及不适当的索赔,搅动,未经授权的交易以及其他经纪人不当行为的指控。最终,SRF拥有快速发展的删除业务,它代表寻求从其行业记录中删除负面和有害客户投诉的经纪人。该公司通过建立成熟的商业房地产以及信托和房地产业务来补充其核心业务领域。
Sichenzia Ross Ference LLP

Latest posts by Sichenzia Ross Ference LLP (see all)